Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (219)
- Scheduling (national classification system) (55)
- Therapeutic goods regulation (36)
- Regulatory compliance (26)
- Prescription medicines (22)
- Advertising (21)
- Non-prescription medicines (21)
- Unique Device Identification (UDI) hub (19)
- In Vitro Diagnostic medical devices (IVDs) (18)
- Registered complementary medicines (17)
- Complementary medicines (16)
- COVID-19 vaccines (14)
- Manufacturing (9)
- Medicines safety (9)
- Safety (9)
- Australian Register of Therapeutic Goods (ARTG) (8)
- Medical devices safety (8)
- Clinical trials (7)
- Legislation (6)
- Vaping hub (6)
- Medicinal cannabis hub (5)
- Over the counter (OTC) medicines (5)
- Breast implant hub (2)
- Compliance and enforcement hub (2)
- Listed medicines (2)
- Shortages (2)
- Advanced therapies (1)
- Cosmetics (1)
- Import and export (1)
- Pharmacovigilance (1)
- TGA conformity assessment certification (1)
Results for
"[search-keyword]"
Search
397 result(s) found, displaying 26 to 50
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
-
PresentationsWebinar Wednesday 5 June
-
WebinarsAbout the inclusion of medical devices to the GCP inspection program and the recent updates to the GCP inspection program guidance document in what to expect and how to prepare for an inspection. A recording of the webinar will be available.
-
PresentationsPresented at the General Practice Conference and Exhibition (Sydney) 2024
-
PresentationsWebinar 1 Wednesday May 8. Webinar 2 Friday May 10.
-
WebinarsAre you interested in applying to be a member of one of our statutory advisory committees? Register for our webinar in May to find out more.
-
PresentationsSee the video recording of our digital transformation program webinar. We demonstrate the first parts of the new online system, being built to make it easier to work with us.
-
PresentationsUpdate on improvements in TGA standards for quality and safety of unapproved vapes
-
PresentationsThis presentation is about our revised guidance on advertising health services which involve cosmetic injectables.
-
WebinarsWe will provide an overview of the Medicines Repurposing Program and how interested stakeholders can propose potential new therapeutic uses of existing medicines.
-
PresentationsThis presentation is an introduction to the new in-house IVD notification form and notification template.
-
PresentationsThis presentation describes the data requirements and the assessment approach need for in-house IVDs, including Companion Diagnostics.
-
PresentationsWe showcased changes to the Clinical Trials Notifications (CTN) form and explained how the review of CTNs for the highest risk medical device clinical trials will operate in practice.
-
WebinarsWe will provide an overview of the Medicines Repurposing Program and how interested stakeholders can propose potential new therapeutic uses of existing medicines.
-
Presentation: NATA TGA IVD information session 1 - Refresher: Regulatory framework for in-house IVDs
PresentationsThis presentation describes the data requirements and the assessment approach need for in-house IVDs, including Companion Diagnostics. -
-
PresentationsWatch our webinar that provides information for prescribers on the vaping reforms, in partnership with the Royal Australian College of General Practitioners (RACGP) and Quit Centre,
-
WebinarsThis webinar provides information on the TGA’s public consultation on the impacts, challenges and opportunities relating to medicine shortages.
-
Committee meetingsAdvisory Committee on Medical Devices (ACMD) meeting
-
Committee meetingsAdvisory Committee on Medicines (ACM) meeting
-
WebinarsLearn about vaping reforms and how these will impact consumers, suppliers and health professionals.
-
Committee meetingsAdvisory Committee on Medical Devices (ACMD) meeting